Nonpulmonary manifestations of cytomegalovirus infection in immunocompromised patients.

AUTOR(ES)

Drew, W L

RESUMO

Nonpulmonary manifestations of cytomegalovirus (CMV) infection in immunocompromised patients include chorioretinitis, gastrointestinal infection, and central nervous system disease. Diagnosis of end organ disease, especially in the gastrointestinal tract, is best substantiated by histologic evidence of CMV inclusions. Positive cultures of CMV provide evidence for supporting infection but do not define actual end organ disease. Satisfactory treatment of the disease can be accomplished with ganciclovir or foscarnet, although these agents only suppress virus replication. In many instances, severe CMV-induced end organ disease in immunocompromised patients will progress despite treatment. In some instances, resistance to the antiviral agent is the basis for drug failure. Patients at high risk for CMV disease can be identified, and studies of prophylaxis are in progress.

Documentos Relacionados

• Early effects of ganciclovir therapy on the quantity of cytomegalovirus DNA in leukocytes of immunocompromised patients.
• Pneumocystis carinii, an opportunist in immunocompromised patients.
• Primary invasive cutaneous Microsporum canis infections in immunocompromised patients.
• The staphylococcal scalded skin syndrome in two elderly immunocompromised patients.
• Commentary: severe varicella/zoster and adenovirus infections in immunocompromised patients.